AI-Native, Beyond the Concept: openKylin Presents Its Vision at FOSSASIA

AI-Native, Beyond the Concept: openKylin Presents Its Vision at FOSSASIA

BEIJING, March 13, 2026 /PRNewswire/ -- At the recent FOSSASIA Summit 2026 in Bangkok, Thailand, developers and open source communities from across Asia and beyond gathered to share the latest advancements in open technologies. China's open source...

YOFC Presents End-to-End All-Optical Solutions for AI-Driven Industry Applications at MWC 2026

YOFC Presents End-to-End All-Optical Solutions for AI-Driven Industry Applications at MWC 2026

BARCELONA, Spain, March 8, 2026 /PRNewswire/ -- At MWC Barcelona 2026, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC) presented its end-to-end all-optical solutions, highlighting their role in supporting AI-driven computing,...

CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse

CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse

WASHINGTON, Feb. 13, 2026 /PRNewswire/ -- CGTN America & CCTV UN releases CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse China Media Group presents the "Prelude to the Spring Festival Gala"...

CHANDO Presents Decade-Long Skin Brightening Research at IMCAS

CHANDO Presents Decade-Long Skin Brightening Research at IMCAS

Research Introduces 577 Epigenetic Mechanism for Asian Skin SHANGHAI, Feb. 7, 2026 /PRNewswire/ -- The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Paris. As a...

Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

Demonstrating Instantaneous Ablation Through High-Voltage Waveforms and Efficient Point-by-Point Pulsed Field Ablation CARDIFF-BY-THE-SEA, Calif., Feb. 6, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company...

MAXHUB Presents Groundbreaking Products at ISE 2026

MAXHUB Presents Groundbreaking Products at ISE 2026

BARCELONA, Spain, Feb. 4, 2026 /PRNewswire/ -- As MAXHUB takes part in Integrated Systems Europe (ISE) 2026, the solution provider in integrated commercial display & UC is presenting its latest developments in collaboration technology. The...

Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ

Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ

SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2...

March Networks Presents New Cloud Storage at Intersec Dubai, Reducing Video Storage Costs by up to 80%

March Networks Presents New Cloud Storage at Intersec Dubai, Reducing Video Storage Costs by up to 80%

Latest product releases showcase new tiered cloud storage model paired with smarter video intelligence, security, and expanded edge hardware. DUBAI, United Arab Emirates, Jan. 12, 2026 /PRNewswire/ -- March Networks®, a global leader in intelligent...

Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration

Hyundai Motor Group Executive Chair Chung Presents 2026 Vision: Customer-Focused Transformation and AI-Driven Ecosystem Collaboration

Executive Chair Chung emphasizes customer-focused transformation and ecosystem strengthening to navigate evolving market dynamics and lead new industry standards Presents strategic priorities, including agile decision-making, ecosystem...

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK,...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu